Frank Morich
Fortune : 20 433 $ au 31/05/2026
Fortune : 20 433 $ au 31/05/2026
Frank M.
Morich is Executive Chairman at Aphaia Pharma AG since 2022.
Dr. Morich is Director at Viewpoint Molecular Targeting, Inc. since 2021.
Dr. Morich is Independent Director at Perspective Therapeutics, Inc. since 2023.
Former roles include Chief Executive Officer & Director at Fujirebio Europe NV from 2005 to 2007, Chief Executive Officer at TME Pharma AG from 2008 to 2010, President & Chief Executive Officer at Takeda A, Deputy Chairman-Supervisory Board at MorphoSys AG from 2015 to 2020, Chairman at Bayer HealthCare AG from 1982 to 2009, Chairman-Executive Board & Chief Executive Officer at AM-Pharma BV, Director at Bayer Corp., Director at Bayer AG from 2000 to 2002, Director & Chief Commercial Officer at Takeda Pharmaceutical Co., Ltd. from 2012 to 2014, Director-Clinical Research at Miles, Inc. from 1982 to 1991, Director at Innate Pharma SA from 2004 to 2010, Director at IsoRay, Inc., Director at Viewpoint (US) from 2021 to 2023, Independent Director at Cue Biopharma, Inc. from 2018 to 2020, Member-Supervisory Board at Neuro3D SA, Executive Vice President-International Operations at Takeda Pharmaceuticals International, Inc. from 2011 to 2012, and Chief Commercial Officer at Takeda Pharmaceuticals International AG from 2011 to 2014.
Education includes a doctorate from Philipps University of Marburg.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CUE BIOPHARMA, INC. 0,02 % | 05/05/2026 | 933 ( 0,02 % ) | 20 433 $ | 31/05/2026 |
| 02/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| PERSPECTIVE THERAPEUTICS, INC. | Directeur/Membre du Conseil | 05/02/2023 |
Viewpoint Molecular Targeting, Inc.
Viewpoint Molecular Targeting, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Directeur/Membre du Conseil | 03/05/2021 |
| Sociétés | Poste | Fin |
|---|---|---|
| CUE BIOPHARMA, INC. | Président | - |
Viewpoint (US) | Directeur/Membre du Conseil | 03/02/2023 |
| MORPHOSYS AG | Directeur/Membre du Conseil | 27/05/2020 |
Takeda Pharmaceuticals International AG
Takeda Pharmaceuticals International AG Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 01/01/2014 |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Directeur/Membre du Conseil | 01/01/2014 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 20 |
|---|---|
Bayer Corp.
Bayer Corp. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical, healthcare & agricultural products | Health Technology |
Bayer AG
Bayer AG Pharmaceuticals: MajorHealth Technology Provides health care, nutrition and high-tech material services | Health Technology |
Takeda Pharmaceutical Co., Ltd.
Takeda Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research, development, manufacturing and marketing of pharmaceutical products | Health Technology |
Fujirebio Europe NV
Fujirebio Europe NV Medical SpecialtiesHealth Technology Develops and markets diagnostic products to improve therapy management and patient health | Health Technology |
MorphoSys AG
MorphoSys AG BiotechnologyHealth Technology Manufactures pharmaceutical products and provides research and development services | Health Technology |
Miles, Inc.
Miles, Inc. Chemicals: Major DiversifiedProcess Industries Chemical company | Process Industries |
Bayer HealthCare AG
Bayer HealthCare AG Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals, healthcare supplements and crop herbicides | Health Technology |
Neuro3D SA
Neuro3D SA Pharmaceuticals: OtherHealth Technology Develops pharmaceutical products to treat the central nervous system | Health Technology |
NOXXON Pharma AG
NOXXON Pharma AG BiotechnologyHealth Technology Provides drug discovery and development services | Health Technology |
Innate Pharma SA
Innate Pharma SA Pharmaceuticals: MajorHealth Technology Develops therapeutic antibodies that harness the immune system to improve cancer treatment and clinical outcomes | Health Technology |
IsoRay, Inc.
IsoRay, Inc. Medical SpecialtiesHealth Technology Produces therapeutic radioactive isotopes | Health Technology |
Takeda A/S
Takeda A/S Financial ConglomeratesFinance Engages in holding or owning securities of companies | Finance |
Philipps University of Marburg
Philipps University of Marburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Takeda Pharmaceuticals International AG
Takeda Pharmaceuticals International AG Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
AM-Pharma BV
AM-Pharma BV BiotechnologyHealth Technology Provides biopharmaceutical products | Health Technology |
Takeda Pharmaceuticals International, Inc.
Takeda Pharmaceuticals International, Inc. Miscellaneous Commercial ServicesCommercial Services Provides management consulting for pharmaceutical businesses | Commercial Services |
Cue Biopharma, Inc.
Cue Biopharma, Inc. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
Viewpoint Molecular Targeting, Inc.
Viewpoint Molecular Targeting, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Commercial Services |
Viewpoint (US) | |
Perspective Therapeutics, Inc.
Perspective Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops medical technology devices | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national